Free shipping on all orders over $ 500

Rovazolac

Cat. No. M54822

All AbMole products are for research use only, cannot be used for human consumption.

Rovazolac Structure
Synonym:

ALX-101

Size Price Availability Quantity
5mg USD 220  USD220 In stock
10mg USD 340  USD340 In stock
25mg USD 650  USD650 In stock
50mg USD 990  USD990 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rovazolac is a liver x receptor (LXR) modulator, which can be used in the study of immune system disorders and atopic dermatitis.

Chemical Information
Molecular Weight 452.45
Formula C21H19F3N2O4S
CAS Number 1454288-88-0
Solubility (25°C) Ethanol 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related Liver X Receptor Products
GW3965 hydrochloride

GW3965 hydrochloride is a selective, orally active non-steroidal synthetic liver X receptor (LXR) agonist.

T0901317

T0901317 is a potent and selective agonist for both LXRα and LXRβ with an EC50 of 20~50 nM. T0901317 activates FXR with an EC50 of 5 μM. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively.

SR9243

SR9243 is a potent and selective LXR inverse agonist.

LXR-623

LXR-623 is a novel liver X-receptor(LXR) agonist with IC50 values of 179 nM and 24 nM for LXR-α and LXR-β, respectively. It is orally bioavailable and readily passes the blood-brain barrier.

GSK2033

GSK2033 is a potent LXR antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Rovazolac, ALX-101 supplier, Liver X Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.